The following article was featured in:
Source:
The Harvard Crimson | Section | News
02/20/2025.
International biotechnology company GlaxoSmithKline is moving its vaccine and infectious disease research teams to Cambridge, in a latest step to strengthen its presence in the Greater Boston area.
Continue on to full article...
